Tobias Else, MD

 Tobias Else photo
Drew O'Donoghue Research Professor of Adrenal Cancer
Associate Professor of Internal Medicine
Section Head and MEND Division Chief of Genetic Medicine
Medical School
Available to mentor
Tobias Else, MD
Tobias Else photo
Associate Professor
  • Qualifications
  • Center Memberships
  • Recent Publications

  • Manage Your Profile

    • Qualifications
    • Metabolism, Endocrinology and Diabetes Fellowship
      University of Michigan, Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes (MEND), Ann Arbor, United States
      2010 - 2014
      Other
    • Internal Medicine Residency
      University of Michigan, Department of Internal Medicine, United States
      2008 - 2010
      Residency
    • MD
      University of Hamburg, Martinistrasse 52, Hamburg, 20246, Germany
      1993 - 2000

    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Rogel Cancer Center

    Recent Publications

     See All Publications
    • Presentation
      Our Cancer Genetics Clinic experience with POT1 cancer predisposition
      Else T. 2026 Jul 22;
    • Journal Article
      Characterization of germline pathogenic variants in melanoma patients.
      Chua YT, Rose D, Yang H, Oh E, Accardo M-L, Koeppe E, Else T, Cha K. Journal of Clinical Oncology, 2026 May 30; 44 (16_suppl): 9590 - 9590. DOI:10.1200/jco.2026.44.16_suppl.9590
    • Journal Article
      Extended follow-up (6 years) of the phase 2 LITESPARK-004 study of belzutifan in participants with von Hippel-Lindau disease–associated neoplasms.
      Srinivasan R, Narayan V, Iliopoulos O, Beckermann KE, Maughan BL, Oudard S, Else T, Maranchie JK, Iversen ABB, Cornell J, Perini RF, Vickery D, Linehan WM, Jonasch E. Journal of Clinical Oncology, 2026 May 29; 44 (16_suppl): 4550 - 4550. DOI:10.1200/jco.2026.44.16_suppl.4550
    • Proceeding / Abstract / Poster
      Genetic Predisposition Syndromes in Adrenocortical Carcinoma
      Zheng I, Wolf K, Hammer G, Osborne J, Else T. 2026 Jun 14;
    • Proceeding / Abstract / Poster
      Genetic Predisposition Syndromes in Adrenocortical Carcinoma
      Zheng I, Wolf K, Hammer G, Osborne J, Else T. 2026 Jun 14;
    • Proceeding / Abstract / Poster
      Extended follow-up (6 years) of the phase 2 LITESPARK-004 study of belzutifan in participants with von Hippel-Lindau disease-associated neoplasms
      Else T. 2026 May 31;
    • Proceeding / Abstract / Poster
      Genetic Predisposition Syndromes in Adrenocortical Carcinoma
      Else T, Zheng I, Wolf K, Hammer G, Osborne J. 2026 May 8;
    • Proceeding / Abstract / Poster
      Genetic Predisposition Syndromes in Adrenocortical Carcinoma
      Else T, Zheng I, Wolf K, Hammer G, Osborne J. 2026 May 8;